Vaughan David Investments LLC Merck & Co., Inc. Transaction History

Vaughan David Investments LLC

  • $4.35 Billion
  • Q3 2024

A detailed history of Vaughan David Investments LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Vaughan David Investments LLC holds 378,685 shares of MRK stock, worth $38.3 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
378,685
Previous 375,379 0.88%
Holding current value
$38.3 Million
Previous $46.5 Million 7.46%
% of portfolio
0.99%
Previous 1.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$111.15 - $128.97 $367,461 - $426,374
3,306 Added 0.88%
378,685 $43 Million
Q2 2024

Aug 07, 2024
BUY
$123.8 - $132.96 $151,531 - $162,743
1,224 Added 0.33%
375,379 $46.5 Million
Q1 2024

May 13, 2024
BUY
$113.24 - $131.95 $207,115 - $241,336
1,829 Added 0.49%
374,155 $49.4 Million
Q4 2023

Jan 29, 2024
BUY
$100.18 - $109.02 $353,635 - $384,840
3,530 Added 0.96%
372,326 $40.6 Million
Q3 2023

Nov 07, 2023
BUY
$102.95 - $114.33 $431,566 - $479,271
4,192 Added 1.15%
368,796 $38 Million
Q2 2023

Aug 02, 2023
BUY
$108.61 - $118.38 $151,402 - $165,021
1,394 Added 0.38%
364,604 $42.1 Million
Q1 2023

May 02, 2023
SELL
$102.94 - $114.86 $267,644 - $298,636
-2,600 Reduced 0.71%
363,210 $38.6 Million
Q4 2022

Feb 07, 2023
BUY
$87.44 - $112.11 $134,482 - $172,425
1,538 Added 0.42%
365,810 $40.6 Million
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $460,181 - $516,962
5,444 Added 1.52%
364,272 $31.4 Million
Q2 2022

Aug 11, 2022
BUY
$83.49 - $94.64 $570,988 - $647,242
6,839 Added 1.94%
358,828 $32.7 Million
Q1 2022

May 09, 2022
BUY
$73.51 - $82.4 $747,890 - $838,337
10,174 Added 2.98%
351,989 $28.9 Million
Q4 2021

Feb 10, 2022
BUY
$72.28 - $90.54 $486,516 - $609,424
6,731 Added 2.01%
341,815 $26.2 Million
Q3 2021

Nov 04, 2021
BUY
$71.68 - $78.83 $352,665 - $387,843
4,920 Added 1.49%
335,084 $25.2 Million
Q2 2021

Aug 11, 2021
BUY
$70.31 - $77.77 $1.18 Million - $1.31 Million
16,848 Added 5.38%
330,164 $25.7 Million
Q1 2021

May 14, 2021
BUY
$68.86 - $81.11 $1.2 Million - $1.42 Million
17,488 Added 5.91%
313,316 $24.2 Million
Q4 2020

Feb 12, 2021
BUY
$71.77 - $79.65 $667,461 - $740,745
9,300 Added 3.25%
295,828 $24.2 Million
Q3 2020

Nov 12, 2020
BUY
$73.18 - $82.95 $370,583 - $420,058
5,064 Added 1.8%
286,528 $23.8 Million
Q2 2020

Aug 07, 2020
BUY
$70.42 - $80.13 $361,325 - $411,147
5,131 Added 1.86%
281,464 $21.8 Million
Q1 2020

May 13, 2020
BUY
$63.36 - $87.82 $781,165 - $1.08 Million
12,329 Added 4.67%
276,333 $21.3 Million
Q4 2019

Feb 13, 2020
BUY
$77.58 - $87.54 $832,433 - $939,304
10,730 Added 4.24%
264,004 $24 Million
Q3 2019

Nov 13, 2019
BUY
$76.08 - $82.93 $342,283 - $373,102
4,499 Added 1.81%
253,274 $21.3 Million
Q2 2019

Aug 14, 2019
BUY
$69.84 - $81.59 $339,073 - $396,119
4,855 Added 1.99%
248,775 $20.9 Million
Q1 2019

May 08, 2019
BUY
$69.58 - $79.36 $531,730 - $606,469
7,642 Added 3.23%
243,920 $20.3 Million
Q4 2018

Feb 08, 2019
BUY
$65.24 - $75.71 $13 Million - $15.1 Million
199,939 Added 550.21%
236,278 $18.1 Million
Q2 2018

Aug 14, 2018
SELL
$50.83 - $59.72 $26,329 - $30,934
-518 Reduced 1.41%
36,339 $2.21 Million
Q1 2018

May 04, 2018
SELL
$50.96 - $59.23 $77,102 - $89,614
-1,513 Reduced 3.94%
36,857 $2.01 Million
Q4 2017

Feb 13, 2018
BUY
$51.62 - $61.64 $68,654 - $81,981
1,330 Added 3.59%
38,370 $2.16 Million
Q3 2017

Nov 09, 2017
SELL
$58.67 - $63.13 $36.2 Million - $38.9 Million
-616,618 Reduced 94.33%
37,040 $2.37 Million
Q3 2017

Nov 08, 2017
BUY
$58.67 - $63.13 $36.1 Million - $38.8 Million
615,240 Added 1601.44%
653,658 $48.7 Million
Q2 2017

Aug 14, 2017
BUY
N/A
38,418
38,418 $2.46 Million

Others Institutions Holding MRK

# of Institutions
3,824
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Vaughan David Investments LLC Portfolio

Follow Vaughan David Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan David Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vaughan David Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email